World Health Statistics 2016 [OP]: Monitoring Health for the Sustainable Development Goals (SDGs) World Health Organization World Health Organization, 2016 | 22184* | 2016 |
Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study TM Walker, TA Kohl, SV Omar, J Hedge, CDO Elias, P Bradley, Z Iqbal, ... The Lancet infectious diseases 15 (10), 1193-1202, 2015 | 629 | 2015 |
Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis P Bradley, NC Gordon, TM Walker, L Dunn, S Heys, B Huang, S Earle, ... Nature communications 6 (1), 10063, 2015 | 607 | 2015 |
Transmission of extensively drug-resistant tuberculosis in South Africa NS Shah, SC Auld, JCM Brust, B Mathema, N Ismail, P Moodley, ... New England Journal of Medicine 376 (3), 243-253, 2017 | 343 | 2017 |
Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing CRyPTIC Consortium and the 100,000 Genomes Project New England Journal of Medicine 379 (15), 1403-1415, 2018 | 334 | 2018 |
Identifying lineage effects when controlling for population structure improves power in bacterial association studies SG Earle, CH Wu, J Charlesworth, N Stoesser, NC Gordon, TM Walker, ... Nature microbiology 1 (5), 1-8, 2016 | 282 | 2016 |
Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study K Schnippel, N Ndjeka, G Maartens, G Meintjes, I Master, N Ismail, ... The lancet respiratory medicine 6 (9), 699-706, 2018 | 271 | 2018 |
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project M Zignol, AS Dean, N Alikhanova, S Andres, AM Cabibbe, DM Cirillo, ... The Lancet infectious diseases 16 (10), 1185-1192, 2016 | 209 | 2016 |
Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study M Zignol, AM Cabibbe, AS Dean, P Glaziou, N Alikhanova, C Ama, ... The Lancet Infectious Diseases 18 (6), 675-683, 2018 | 158 | 2018 |
Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations TC Rodwell, F Valafar, J Douglas, L Qian, RS Garfein, A Chawla, J Torres, ... Journal of clinical microbiology 52 (3), 781-789, 2014 | 157 | 2014 |
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis TM Walker, P Miotto, CU Köser, PW Fowler, J Knaggs, Z Iqbal, M Hunt, ... The Lancet Microbe 3 (4), e265-e273, 2022 | 154 | 2022 |
Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe M Hunt, P Bradley, SG Lapierre, S Heys, M Thomsit, MB Hall, KM Malone, ... Wellcome open research 4, 2019 | 127 | 2019 |
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen N Ndjeka, K Schnippel, I Master, G Meintjes, G Maartens, R Romero, ... European Respiratory Journal 52 (6), 2018 | 121 | 2018 |
Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strains LT Daum, JD Rodriguez, SA Worthy, NA Ismail, SV Omar, AW Dreyer, ... Journal of clinical microbiology 50 (12), 3831-3837, 2012 | 115 | 2012 |
Modernizing Medical Microbiology (MMM) Informatics Group. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a … TM Walker, TA Kohl, SV Omar, J Hedge, C Del Ojo Elias, P Bradley, ... Lancet Infect Dis 15 (10), 1193-1202, 2015 | 110 | 2015 |
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: a multicountry analysis of cross-sectional data AS Dean, M Zignol, AM Cabibbe, D Falzon, P Glaziou, DM Cirillo, ... PLoS medicine 17 (1), e1003008, 2020 | 109 | 2020 |
Defining bedaquiline susceptibility, resistance, cross-resistance and associated genetic determinants: a retrospective cohort study NA Ismail, SV Omar, L Joseph, N Govender, L Blows, F Ismail, H Koornhof, ... EBioMedicine 28, 136-142, 2018 | 108 | 2018 |
Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004–12: a time series analysis A Nanoo, A Izu, NA Ismail, C Ihekweazu, I Abubakar, D Mametja, ... The Lancet infectious diseases 15 (9), 1066-1076, 2015 | 99 | 2015 |
Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey NA Ismail, L Mvusi, A Nanoo, A Dreyer, SV Omar, S Babatunde, ... The Lancet Infectious Diseases 18 (7), 779-787, 2018 | 98 | 2018 |
A multilaboratory, multicountry study to determine MIC quality control ranges for phenotypic drug susceptibility testing of selected first-line antituberculosis drugs, second … K Kaniga, DM Cirillo, S Hoffner, NA Ismail, D Kaur, N Lounis, B Metchock, ... Journal of Clinical Microbiology 54 (12), 2963-2968, 2016 | 93* | 2016 |